Treatment Update: Myelodysplastic Syndromes (MDS)

Topics Covered
We invite you to learn more about:
• Myelodysplastic syndromes subtypes
• Current and emerging treatments
• Side-effects management
• The importance of communication with your healthcare team
Speaker
Mikkael A. Sekeres, MD
Professor of Medicine
Chief, Division of Hematology
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL

[@billygarner7362]

When on Reblozyl toward the end of its course fatigue was constant. Also shortness of breath accompanied the low Hb. I am now on Azacitidine and have finished the third course. My Hb is up from 7-8 to near 11. The fatigue is improved and SOB has gone away. Side effects have been minimal, constipation being the main one. I hope for a long successful therapy. After it comes BMT. I’m not looking forward to that.

[@Cincyseller513]

You are an amazing Dr. Thank you for all of this info providing the medical side with studies and acknowledging how our immune system can cure us and adding diet is important :)

[@Anti-leftist7777]

I have ASXL1, excess blasts @15%, low white blood cells, platelets at 10 up to 30 when I have transfusions twice a week. One cycle Vidaza completed with a few coming and a stem cell transplant in a couple months. Additionally multiple myeloma just diagnosed. Chances of success, years?
The ASXL1 concerns me.

[@ronoconnor8971]

Procrit weekly has my hgb to +10 but my dizziness and larthogy is very bad. Ive been anemic for many years and was diagnosed with mds last year

[@at6969]

Excellent